The market was valued at $194.8 million in 2012.
The rise in diabetes worldwide has led to an increased adoption of continuous glucose monitoring devices, according to the report. Much of the CGM market can be attributed to an increase in technological innovations, such as the artificial pancreas.
North America will generate the highest revenue in the CGM market due to quick acceptance of innovative technology and an increase in the patient pool. Asia Pacific’s market is poised to grow at a faster rate due to a large patient pool, geographical expansion of markets and increases in income levels and standard of living, according to the report.
More Articles on Medical Device Markets:
Global Insulin Delivery Devices Market to Reach $14B by 2019
Cardiovascular Information System Market to Reach $233M by 2018
What the Increase in Device Recalls Means for Hospitals
